sumatriptan has been researched along with selurampanel in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brand, R; Campos, V; Diener, HC; Evers, S; Göbel, H; Gomez-Mancilla, B; Hariry, S; Johns, D; Jürgens, TP; Kalkman, HO; Pezous, N; Sommer, C; Sommer, M; Straube, A | 1 |
1 trial(s) available for sumatriptan and selurampanel
| Article | Year |
|---|---|
Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks.
Topics: Acute Disease; Adult; Anticonvulsants; Double-Blind Method; Female; Humans; Male; Middle Aged; Migraine Disorders; Placebos; Quinazolinones; Receptors, AMPA; Serotonin 5-HT1 Receptor Agonists; Sumatriptan; Treatment Outcome | 2014 |